State of the art and recent developments of radiopharmaceuticals for pancreatic neuroendocrine tumors imaging.

CONCLUSION: This paper shows an overview of the RPs used so far in the imaging of pNETs with insight on potential new radiopharmaceuticals currently under clinical evaluation.
PMID: 30843499 [PubMed - as supplied by publisher]

Source: Current Radiopharmaceuticals - March 8, 2019 Category: Radiology Tags: Curr Radiopharm Source Type: research